Specialty Vision is an online directory, not a healthcare provider. Listed practices are not owned or operated by us.

Specialty Vision is an online directory and does not provide healthcare services. Listed practices and doctors are not owned, operated, or employed by Specialty Vision.

Sudden Vision Changes in AMD: Know When to Act

Understanding Age-Related Macular Degeneration

Understanding Age-Related Macular Degeneration

AMD damages the macula, which is the small central area of the retina responsible for sharp, detailed vision. The macula allows you to read, recognize faces, and see fine details. When the macula is damaged, the center of your visual field becomes blurred, distorted, or dark, while your side vision typically remains intact.

There are two main types of AMD. Dry AMD is more common and involves the gradual thinning of the macula. Wet AMD is less common but more likely to cause rapid, severe vision loss.

Wet AMD occurs when new, abnormal blood vessels grow beneath the retina. This process is called choroidal neovascularization (CNV). These fragile vessels can leak blood and fluid, which pools beneath the photoreceptor layer. The photoreceptor layer converts light into signals sent to the brain. When fluid or blood disrupts this layer, the retina cannot function normally, and vision changes can happen quickly.

Most people who develop wet AMD had dry AMD first. About ten percent of all AMD cases become wet AMD (American Macular Degeneration Foundation). A study of conversion rates found that 2% of patients with early dry AMD, 6.1% with intermediate dry AMD, and 6.7% with advanced dry AMD converted to the wet form (Review of Optometry). More advanced stages of dry AMD carry a higher risk of conversion, which is why regular monitoring is so important.

Who Is Affected and Risk Factors

AMD is a widespread condition. Among 24,129,807 Medicare beneficiaries aged 65 and older in 2021, the national prevalence of AMD was 10.40%. The prevalence of wet AMD specifically was 2.14% (PMC, NIH, 2024). Globally, AMD is expected to affect approximately 288 million people by 2040 (American Macular Degeneration Foundation).

Several factors increase the likelihood of developing AMD or converting from dry to wet AMD. Understanding these risk factors can help you and your retina specialist plan an appropriate monitoring schedule.

  • Older age is the strongest risk factor for AMD.
  • Cigarette smoking significantly increases the risk of developing AMD and of converting from dry to wet AMD.
  • Genetic factors play a role. A family history of AMD raises your risk.
  • Female patients and white patients have been found to have a higher risk of conversion from dry to wet AMD (Review of Optometry).
  • Having wet AMD in one eye increases the risk that the other eye may also convert.

If you have been diagnosed with wet AMD in one eye and dry AMD in the other, your retina specialist will monitor the dry eye closely. Research shows that patients with wet AMD in one eye and dry AMD in the fellow eye are more likely to convert than patients with dry AMD in both eyes (Review of Optometry). Active choroidal neovascularization in one eye is associated with a higher conversion risk in the other eye.

Signs and Symptoms of Sudden Vision Changes

Wet AMD can start suddenly. You will not feel pain, but you may notice distinct changes in your central vision. These warning signs require prompt attention.

  • Straight lines appearing wavy, bent, or distorted. This is one of the earliest and most recognizable signs.
  • A dark spot or blind spot forming in the center of your vision. This blank area may appear gray, red, or black.
  • Sudden blurriness in the center of your visual field that was not there before.
  • Colors appearing less vivid or washed out compared to before.
  • Difficulty reading, recognizing faces, or performing tasks that require detailed central vision.

In wet AMD, the abnormal blood vessels beneath the retina can leak blood or fluid rapidly. This pooling of fluid lifts and distorts the macula, disrupting the photoreceptors almost immediately. Unlike dry AMD, which may take months or years to cause noticeable changes, wet AMD can alter your vision within days or even hours.

An Amsler grid is a simple tool that looks like graph paper with a dot in the center. Your retina specialist may recommend using it daily to monitor your vision at home. To use it, cover one eye at a time, focus on the center dot, and notice whether any lines appear wavy, broken, or missing. If you see any distortion or new blank areas, contact a retina specialist right away. This daily check takes less than a minute and can help you catch changes early.

Diagnosis and Testing

If you notice sudden vision changes, a retina specialist will perform a comprehensive dilated eye exam. During this exam, special drops widen the pupil so the specialist can see the retina clearly. The retina specialist will look for signs of fluid, blood, or abnormal blood vessel growth beneath the macula.

Several advanced imaging tests help confirm a diagnosis of wet AMD and guide treatment decisions.

  • Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina. It can detect even small amounts of fluid beneath or within the retinal layers.
  • Fluorescein angiography involves injecting a special dye into the arm and photographing the retina as the dye passes through the blood vessels. This reveals leaking or abnormal vessels.
  • OCT angiography (OCTA) is a newer, noninvasive imaging method that shows blood vessel structures without the need for a dye injection.

Research indicates that the earlier you start receiving treatment for wet AMD, the better your visual outcome is likely to be. One recent study suggests that starting treatment within the first 48 hours of symptom onset may lead to better results. A study supported by the American Macular Degeneration Foundation is showing that time-to-treatment may be the single most important factor in preserving vision. Delaying evaluation even by days or weeks can allow more damage to accumulate in the macula.

Treatment Options for Wet AMD

The primary treatment for wet AMD is intravitreal injection (an injection of medication directly into the eye) of anti-VEGF drugs. VEGF stands for vascular endothelial growth factor, a protein that promotes the growth of abnormal blood vessels. Anti-VEGF drugs block this protein, helping to stop the growth and leakage of these vessels. These injections may preserve remaining vision and, in many cases, recover some lost vision.

Wet AMD is a chronic condition that can be managed effectively with consistent treatment but not reversed entirely. Stopping or delaying injections without guidance from a retina specialist can allow the disease to become active again.

Several anti-VEGF medications are used to treat wet AMD. Each has different dosing intervals and properties.

  • Eylea (aflibercept) is one of the most commonly used anti-VEGF agents. After an initial series of monthly injections, it is typically given every 4 to 8 weeks.
  • Eylea HD (high-dose aflibercept) allows extended dosing intervals. Some patients receive injections every 8 to 16 weeks after loading doses.
  • Lucentis (ranibizumab) was the first anti-VEGF medication approved for eye use and is typically given every 4 weeks.
  • Avastin (bevacizumab) is FDA-approved for cancer treatment and is used off-label for eye conditions, including wet AMD. It is typically given every 4 to 6 weeks.
  • Vabysmo (faricimab) is a bispecific antibody that targets two pathways involved in wet AMD. Dosing can range from every 4 to 16 weeks depending on response.

Most anti-VEGF treatment plans begin with a loading phase of three monthly injections. After this initial phase, your retina specialist will determine the best interval for ongoing injections based on how your eye responds. Some patients need injections monthly, while others may extend to every two or three months. Your retina specialist will use OCT imaging at each visit to check for fluid and decide on the next treatment step.

Researchers continue to develop new medications that may be more effective and longer lasting, potentially reducing the number of injections needed. There is also active research into treatments that may slow the progression of dry AMD before it converts to the wet form. Complement inhibitors such as Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) are approved for geographic atrophy, an advanced form of dry AMD, but these medications are not used for wet AMD.

What to Expect During and After Treatment

An intravitreal injection is performed in a retina specialist's office. The eye is numbed with anesthetic drops, and the surface is cleaned with an antiseptic solution. The injection itself takes only seconds. Most patients report mild pressure or discomfort during the procedure. Afterward, you may notice a gritty feeling or mild redness for a day or two.

After each injection, your retina specialist will schedule a follow-up visit that typically includes an OCT scan to check for fluid in the retina. Treatment is adjusted based on these results. If fluid returns, your retina specialist may shorten the interval between injections. If the retina remains dry, the interval may be extended. This individualized approach is called a treat-and-extend protocol.

Anti-VEGF treatment can stabilize or improve vision in many patients. However, results vary from person to person. Some patients regain several lines of vision on the eye chart, while others maintain their current level of vision. The goal of treatment is to prevent further damage and preserve as much vision as possible. Early and consistent treatment gives you the best chance of a favorable outcome.

Living With AMD and Monitoring Your Vision

If you have been diagnosed with any stage of AMD, daily self-monitoring is important. Use an Amsler grid each morning. Check each eye separately. If you notice any new distortion, waviness, dark spots, or blurring that was not there the day before, contact a retina specialist promptly. Do not wait for your next scheduled appointment.

While no lifestyle change can reverse AMD, certain habits may support eye health and potentially slow progression.

  • Stop smoking. Smoking is one of the most significant modifiable risk factors for AMD and for conversion from dry to wet AMD.
  • Eat a diet rich in leafy green vegetables, fish, and other foods high in omega-3 fatty acids and antioxidants.
  • Talk to your retina specialist about whether AREDS2 vitamin supplements are appropriate for your specific stage of AMD.
  • Wear sunglasses that block UV light when outdoors.
  • Maintain a healthy weight and stay physically active.

If AMD has affected your central vision, low vision aids and rehabilitation services can help you maintain independence. Magnifying devices, specialized lighting, large-print materials, and screen readers can make daily tasks easier. A retina specialist or low vision specialist can recommend resources based on your specific needs.

When to See a Retina Specialist Immediately

Certain vision changes require urgent evaluation. If you experience any of the following, see a retina specialist or go to the emergency room immediately. Do not wait.

  • A sudden increase in the number of floaters in your vision.
  • Flashes of light, especially in your peripheral vision.
  • A curtain, shadow, or dark area spreading across your visual field.
  • Sudden vision loss in one eye.
  • New distortion of straight lines, especially if you have been diagnosed with dry AMD.
  • A new dark spot or gray area in the center of your vision.

When wet AMD develops, abnormal blood vessels can leak blood and fluid rapidly, damaging the delicate photoreceptor cells of the macula. Every hour that passes without treatment allows more damage to occur. Research from the American Macular Degeneration Foundation suggests that time-to-treatment may be the most important factor in preserving your vision. Contacting a retina specialist at the first sign of a sudden vision change gives you the best opportunity to protect your remaining sight.

If you notice a change in your vision and are uncertain whether it is serious, err on the side of caution. Contact a retina specialist the same day if possible. Describe what you see, when it started, and which eye is affected. Many retina practices reserve same-day or next-day appointments for patients with urgent vision changes. It is far better to have a normal examination than to delay evaluation of a potentially sight-threatening condition.

Questions and Answers

Yes. Wet AMD can develop between scheduled appointments, sometimes within days. This is why daily home monitoring with an Amsler grid is so valuable. A normal exam does not ensure that your condition will remain stable until your next visit. If you notice any new distortion, dark spots, or blurriness, contact a retina specialist right away regardless of when your last appointment was.

Many patients with wet AMD require ongoing treatment for years. Some patients can gradually extend the time between injections as their condition stabilizes. Others may need consistent monthly or bimonthly treatments. Your retina specialist will tailor the treatment schedule to your specific response. Stopping treatment without medical guidance can allow the disease to become active again and cause further vision loss.

There is no proven way to prevent conversion from dry to wet AMD. However, stopping smoking, maintaining a healthy diet, and following your retina specialist's recommended monitoring schedule can help. AREDS2 vitamin supplements have been shown to reduce the risk of progression in certain stages of dry AMD. Your retina specialist can advise whether these supplements are appropriate for you. Daily use of an Amsler grid allows you to detect changes early, which is critical for timely treatment.

Delaying treatment can lead to additional and potentially irreversible damage to the macula. The abnormal blood vessels in wet AMD can continue leaking blood and fluid, destroying photoreceptor cells that cannot regenerate. Studies indicate that earlier treatment leads to better visual outcomes. Even a delay of a few weeks may reduce the amount of vision that can be preserved or recovered. If you suspect a sudden change in your vision, seek evaluation as quickly as possible.

The eye is numbed with anesthetic drops before the injection, so most patients feel only mild pressure or brief discomfort. Some patients describe a sensation of fullness in the eye. The injection itself takes only seconds. Mild soreness or grittiness may last for a day or two afterward. While the idea of an eye injection can be concerning, most patients tolerate the procedure well and find that the discomfort is far less than they expected.